title: Optimization of storage stability of lyophilized actin using combinations of disaccharides and dextran.
abstract: The storage stability of a dry protein depends on the structure of the dried protein, as well as on the storage temperature relative to the glass transition temperature of the dried preparation. Disaccharides are known to preserve the native conformation of a dried protein; however, the resulting T(g) of the sample may be too low ensure adequate storage stability. On the other hand, formulations dried with high molecular weight carbohydrates, such as dextran, have higher glass transition temperatures, but fail to preserve native protein conformation. We tested the hypothesis that optimizing both protein structure and T(g) by freeze-drying actin with mixtures of disaccharides and dextran would result in increased storage stability compared to actin dried with either disaccharide or dextran alone. Protein structure in the dried solid was analyzed immediately after lyophilization and after storage at elevated temperatures with infrared spectroscopy, and after rehydration by infrared and circular dichroism spectroscopy. Structural results were related to the polymerization activity recovered after rehydration. Degradation was noted with storage for formulations containing either sucrose, trehalose, or dextran alone. Slight increases in T(g) observed in trehalose formulations compared to sucrose formulations did not result in appreciable increases in storage stability. Addition of dextran to sucrose or trehalose increased formulation T(g) without affecting the capacity of the sugar to inhibit protein unfolding during lyophilization and resulted in improved storage stability. Also, dextran provides an excellent amorphous bulking agent, which can be lyophilized rapidly with formation of strong, elegant cake structure. These results suggest that the strategy of using a mixture of disaccharide and polymeric carbohydrates can optimize protein storage stability.
authors.affiliation: University of Colorado Center for Pharmaceutical Biotechnology, Denver, Colorado 80262, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Allison
authors.forename: M C
authors.initials: MC
authors.lastname: Manning
authors.forename: T W
authors.initials: TW
authors.lastname: Randolph
authors.forename: K
authors.initials: K
authors.lastname: Middleton
authors.forename: A
authors.initials: A
authors.lastname: Davis
authors.forename: J F
authors.initials: JF
authors.lastname: Carpenter
mesh_terms: D000199:Actins / Q000737:chemistry*; D000818:Animals; D002942:Circular Dichroism; D003911:Dextrans / Q000737:chemistry*; D004355:Drug Stability; D004356:Drug Storage; D005079:Excipients / Q000737:chemistry; D005612:Freeze Drying; D006801:Humans; D007231:Infant, Newborn; D017433:Protein Structure, Secondary; D011817:Rabbits; D017550:Spectroscopy, Fourier Transform Infrared; D013329:Structure-Activity Relationship; D013395:Sucrose / Q000737:chemistry*; D013696:Temperature; D014199:Trehalose / Q000737:chemistry*; D014867:Water / Q000737:chemistry
chemical_list: D000199:Actins; D003911:Dextrans; D005079:Excipients; D014867:Water; D013395:Sucrose; D014199:Trehalose